Review




Structured Review

Genechem control lentiviral particles shctrl
Exploration of potential downstream mechanism and upstream regulators of CCDC137. A Heatmap shows DEGs identified by RNA sequencing in <t>T24-shCtrl</t> and T24-shCCDC137-1 cells. B Bar plot displays GO and KEGG functional enrichment results of downregulated DEGs from RNA sequencing. C GSVA-Hallmark pathway enrichment analysis displayed differences between CCDC137 positive (CCDC137 +) and CCDC137 negative (CCDC137 −) cells based on single-cell sequencing data. D mRNA and protein expression of stearoyl-CoA desaturase (SCD) were detected by qRT-PCR and Western blot. E DecoupleR was used to analyze differences in transcription factor activity between CCDC137 + and CCDC137 − epithelial cells in single-cell sequencing data. F TF-Target Finder was employed to identify potential upstream transcription factors of CCDC137. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance
Control Lentiviral Particles Shctrl, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+lentiviral+particles+shctrl/lentiviral+particles/pmc12462137-114-6-13
Average 86 stars, based on 1 article reviews
control lentiviral particles shctrl - by Bioz Stars, 2026-11
86/100 stars

Images

1) Product Images from "CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD"

Article Title: CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD

Journal: Journal of Translational Medicine

doi: 10.1186/s12967-025-07033-w

Exploration of potential downstream mechanism and upstream regulators of CCDC137. A Heatmap shows DEGs identified by RNA sequencing in T24-shCtrl and T24-shCCDC137-1 cells. B Bar plot displays GO and KEGG functional enrichment results of downregulated DEGs from RNA sequencing. C GSVA-Hallmark pathway enrichment analysis displayed differences between CCDC137 positive (CCDC137 +) and CCDC137 negative (CCDC137 −) cells based on single-cell sequencing data. D mRNA and protein expression of stearoyl-CoA desaturase (SCD) were detected by qRT-PCR and Western blot. E DecoupleR was used to analyze differences in transcription factor activity between CCDC137 + and CCDC137 − epithelial cells in single-cell sequencing data. F TF-Target Finder was employed to identify potential upstream transcription factors of CCDC137. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance
Figure Legend Snippet: Exploration of potential downstream mechanism and upstream regulators of CCDC137. A Heatmap shows DEGs identified by RNA sequencing in T24-shCtrl and T24-shCCDC137-1 cells. B Bar plot displays GO and KEGG functional enrichment results of downregulated DEGs from RNA sequencing. C GSVA-Hallmark pathway enrichment analysis displayed differences between CCDC137 positive (CCDC137 +) and CCDC137 negative (CCDC137 −) cells based on single-cell sequencing data. D mRNA and protein expression of stearoyl-CoA desaturase (SCD) were detected by qRT-PCR and Western blot. E DecoupleR was used to analyze differences in transcription factor activity between CCDC137 + and CCDC137 − epithelial cells in single-cell sequencing data. F TF-Target Finder was employed to identify potential upstream transcription factors of CCDC137. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance

Techniques Used: RNA Sequencing, Functional Assay, Sequencing, Expressing, Quantitative RT-PCR, Western Blot, Activity Assay

In vivo validation of CCDC137 regulating tumor growth. A Subcutaneous xenograft models were established in nude mice to validate the regulatory role of CCDC137 in tumor growth. B Tumor volume growth curves were plotted over 28 days after tumor cell inoculation. C Tumor weights of T24-shCtrl and T24-shCCDC137-1 groups were measured on day 28. D The Graphical Abstract described the key results in this study. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance
Figure Legend Snippet: In vivo validation of CCDC137 regulating tumor growth. A Subcutaneous xenograft models were established in nude mice to validate the regulatory role of CCDC137 in tumor growth. B Tumor volume growth curves were plotted over 28 days after tumor cell inoculation. C Tumor weights of T24-shCtrl and T24-shCCDC137-1 groups were measured on day 28. D The Graphical Abstract described the key results in this study. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance

Techniques Used: In Vivo, Biomarker Discovery

Related Articles

Control:

Article Title: CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD
Article Snippet: Antibodies were diluted in antibody dilution buffer (Cat. #PS119L, EpiZyme) as follows: anti-CCDC137 (1:1000; Cat. #27201-1-AP, Proteintech), anti-β-actin (1:10000; Cat. #GXP6564, Genxspan), anti-SCD (1:3000; Cat. #28678-1-AP, Proteintech), anti-AKT (1:5000; Cat. #10176-2-AP, Proteintech), anti-p-AKT (1:5000; Cat. #66444-1-Ig, Proteintech), HRP-Goat Anti-Mouse Recombinant Secondary Antibody (1:10,000; Cat. #RGAM001, Proteintech), HRP-Goat Anti-Rabbit Recombinant Secondary Antibody (1:10,000; Cat. #RGAR001, Proteintech). .. The shCCDC137 lentiviral particles and corresponding control lentiviral particles (shCtrl) were purchased from Genechem Co., Ltd (Shanghai, China). ..



Similar Products

86
Genechem control lentiviral particles shctrl
Exploration of potential downstream mechanism and upstream regulators of CCDC137. A Heatmap shows DEGs identified by RNA sequencing in <t>T24-shCtrl</t> and T24-shCCDC137-1 cells. B Bar plot displays GO and KEGG functional enrichment results of downregulated DEGs from RNA sequencing. C GSVA-Hallmark pathway enrichment analysis displayed differences between CCDC137 positive (CCDC137 +) and CCDC137 negative (CCDC137 −) cells based on single-cell sequencing data. D mRNA and protein expression of stearoyl-CoA desaturase (SCD) were detected by qRT-PCR and Western blot. E DecoupleR was used to analyze differences in transcription factor activity between CCDC137 + and CCDC137 − epithelial cells in single-cell sequencing data. F TF-Target Finder was employed to identify potential upstream transcription factors of CCDC137. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance
Control Lentiviral Particles Shctrl, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+lentiviral+particles+shctrl/lentiviral+particles/pmc12462137-114-6-13
Average 86 stars, based on 1 article reviews
control lentiviral particles shctrl - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology control shrna shctrl lentiviral particles
Exploration of potential downstream mechanism and upstream regulators of CCDC137. A Heatmap shows DEGs identified by RNA sequencing in <t>T24-shCtrl</t> and T24-shCCDC137-1 cells. B Bar plot displays GO and KEGG functional enrichment results of downregulated DEGs from RNA sequencing. C GSVA-Hallmark pathway enrichment analysis displayed differences between CCDC137 positive (CCDC137 +) and CCDC137 negative (CCDC137 −) cells based on single-cell sequencing data. D mRNA and protein expression of stearoyl-CoA desaturase (SCD) were detected by qRT-PCR and Western blot. E DecoupleR was used to analyze differences in transcription factor activity between CCDC137 + and CCDC137 − epithelial cells in single-cell sequencing data. F TF-Target Finder was employed to identify potential upstream transcription factors of CCDC137. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance
Control Shrna Shctrl Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+lentiviral+particles+shctrl/Control+shRNA+Lentiviral+Particles-A/pm40339980-253-8-16
Average 96 stars, based on 1 article reviews
control shrna shctrl lentiviral particles - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Genecopoeia control shrna lentiviral particles (shctrl) (lpp-cshctr001-lvru6mh-025-c)
NSDHL knockdown suppresses tumor initiation and growth in tumor spheroid-injected xenograft tumor models. (A) Representative flow cytometry histogram of mCherry-positive cells sorted from NSDHL <t>shRNA</t> (shNSDHL) or control shRNA <t>(shCtrl)-tagged</t> mCherry-transduced MCF-7 cells. (B) Representative confocal images of mCherry-positive cells in shNSDHL- or shCtrl-spheroids. mCherry (red) and DAPI (blue). Scale bar: 100 μm C-E. NSDHL mRNA and protein levels and representative western blot images of NSDHL and mCherry in shNSDHL-MCF-7 spheroids relative to shCtrl-MCF-7 spheroids by qRT-PCR ( n = 6) and western blot analysis ( n = 6). F-G. Representative flow cytometry dot plots and quantification of CD44+/CD24 − cells in shCtrl and shNSDHL MCF-7 spheroids ( n = 3). H-I. Representative flow cytometry dot plots and quantification of ALDH + cells in shCtrl- and shNSDHL-MCF-7 spheroids using ALDEFLUOR assay ( n = 3). J. Tumor volume was measured weekly in shCtrl- or shNSDHL-MCF-7 spheroid-injected mice ( n = 6) for 56 days post-injection. K-L. Gross images and wet weights of tumors removed from shNSDHL- or shCtrl-MCF-7 spheroid-injected mice ( n = 6) at 56 days post-injection. M-N. Representative western blot images and quantification data of NSDHL proteins in shNSDHL-MCF-7 tumors compared to shCtrl-MCF-7 tumors ( n = 6). O. Representative NSDHL and mCherry immunohistochemistry images and H&E images of shNSDHL- or shCtrl-MCF-7 tumor tissues. Scale bar: 100 μm. The bar graph shows the mean ± standard deviation. * P < 0.05, ** P < 0.01, *** P < 0.001 as compared to shCtrl using unpaired t-tests
Control Shrna Lentiviral Particles (Shctrl) (Lpp Cshctr001 Lvru6mh 025 C), supplied by Genecopoeia, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+lentiviral+particles+shctrl/shrna+lentiviral+particle/pmc11549796-42-6-15
Average 90 stars, based on 1 article reviews
control shrna lentiviral particles (shctrl) (lpp-cshctr001-lvru6mh-025-c) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
OriGene origene lentiviruses shctrl
Depletion of RALA or RALB reduces MDA-MB-468 tumor growth and is associated with changes in the tumor microenvironment. ( A ) Western blots displaying RALA and RALB expression in the MDA-MB-468 shRNA control <t>(shCTRL),</t> shRALA, and shRALB cells. ImageJ was used for quantification. ( B , C ) Effects of stable knockdown of RALA or RALB in MDA-MB-468 cells on 2D growth as measured by MTT (( B ), n = 4), and 3D growth as measured by GILA (( C ), n = 4) *, p < 0.05. ( D ) Stable knockdown of RALA or RALB had no effect on MDA-MB-468 cell migration (left: representative images, right: composite mean values, n = 2). ( E ) Comparison of tumor growth following orthotopic mammary fat pad injection of MDA-MB-468 shCtrl ( n = 20), shRALA ( n = 20), or shRALB ( n = 20). Results were combined from three independent experiments. ( F – H ) MDA-MB-468 shCTRL ( n = 9), shRALA ( n = 10), and shRALB ( n = 10) tumors IHC stained for ( F ) Ki-67, ( G ) CC3, or ( H ) CD31. ROIs were determined on each image separating the tumor from stroma before color deconvolution to extract DAB staining. A signal threshold (equivalent for each image) was then applied to the samples before measurement of the ROIs was performed to measure the % area of target staining in each region. Three representative photos from each sample were separately analyzed, and the mean values were used for comparisons among groups. *, p < 0.05. ( I ) MDA-MB-468 tumors stained with Masson’s Trichrome, denoted by white arrows, to analyze the collagen deposition in shCTRL ( n = 7), shRALA ( n = 8), or shRALB ( n = 9) MDA-MB-468 tumors. *, p < 0.05. ( J , K ) Graphs summarize the relative amounts of secreted proteins detected in the conditioned media from the MDA-MB-468 shCTRL, shRALA, and shRALB cultures.
Origene Lentiviruses Shctrl, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+lentiviral+particles+shctrl/Lentiviral+Control+Particles/pmc11394424-69-7-7
Average 95 stars, based on 1 article reviews
origene lentiviruses shctrl - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology control shrna lentiviral particles shctrl
Fig. 2 NSDHL knockdown decreases viability, proliferation, and colony and sphere formation abilities of BT-20 and MDA-MB-231 cells. a, b Data of cell viability and cell cycle in BT-20 and MDA-MB-231 cells transfected with NSDHL <t>siRNA</t> or control siRNA (20 nM); c, d Representative images and data analyzed in colony formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); e Representative image and data analyzed in 3D sphere formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). All data represent the means ± standard deviations of three independent experiments, each performed in triplicates. *p < 0.05, **p < 0.01, ***p < 0.001
Control Shrna Lentiviral Particles Shctrl, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+lentiviral+particles+shctrl/Control+shRNA+Lentiviral+Particles-A/pm32366230-70-51-57
Average 96 stars, based on 1 article reviews
control shrna lentiviral particles shctrl - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology scramble control shrna shctrl
Fig. 2 NSDHL knockdown decreases viability, proliferation, and colony and sphere formation abilities of BT-20 and MDA-MB-231 cells. a, b Data of cell viability and cell cycle in BT-20 and MDA-MB-231 cells transfected with NSDHL <t>siRNA</t> or control siRNA (20 nM); c, d Representative images and data analyzed in colony formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); e Representative image and data analyzed in 3D sphere formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). All data represent the means ± standard deviations of three independent experiments, each performed in triplicates. *p < 0.05, **p < 0.01, ***p < 0.001
Scramble Control Shrna Shctrl, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+lentiviral+particles+shctrl/Control+shRNA+Lentiviral+Particles-A/pm31493869-47-4-15
Average 96 stars, based on 1 article reviews
scramble control shrna shctrl - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


Exploration of potential downstream mechanism and upstream regulators of CCDC137. A Heatmap shows DEGs identified by RNA sequencing in T24-shCtrl and T24-shCCDC137-1 cells. B Bar plot displays GO and KEGG functional enrichment results of downregulated DEGs from RNA sequencing. C GSVA-Hallmark pathway enrichment analysis displayed differences between CCDC137 positive (CCDC137 +) and CCDC137 negative (CCDC137 −) cells based on single-cell sequencing data. D mRNA and protein expression of stearoyl-CoA desaturase (SCD) were detected by qRT-PCR and Western blot. E DecoupleR was used to analyze differences in transcription factor activity between CCDC137 + and CCDC137 − epithelial cells in single-cell sequencing data. F TF-Target Finder was employed to identify potential upstream transcription factors of CCDC137. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance

Journal: Journal of Translational Medicine

Article Title: CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD

doi: 10.1186/s12967-025-07033-w

Figure Lengend Snippet: Exploration of potential downstream mechanism and upstream regulators of CCDC137. A Heatmap shows DEGs identified by RNA sequencing in T24-shCtrl and T24-shCCDC137-1 cells. B Bar plot displays GO and KEGG functional enrichment results of downregulated DEGs from RNA sequencing. C GSVA-Hallmark pathway enrichment analysis displayed differences between CCDC137 positive (CCDC137 +) and CCDC137 negative (CCDC137 −) cells based on single-cell sequencing data. D mRNA and protein expression of stearoyl-CoA desaturase (SCD) were detected by qRT-PCR and Western blot. E DecoupleR was used to analyze differences in transcription factor activity between CCDC137 + and CCDC137 − epithelial cells in single-cell sequencing data. F TF-Target Finder was employed to identify potential upstream transcription factors of CCDC137. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance

Article Snippet: The shCCDC137 lentiviral particles and corresponding control lentiviral particles (shCtrl) were purchased from Genechem Co., Ltd (Shanghai, China).

Techniques: RNA Sequencing, Functional Assay, Sequencing, Expressing, Quantitative RT-PCR, Western Blot, Activity Assay

In vivo validation of CCDC137 regulating tumor growth. A Subcutaneous xenograft models were established in nude mice to validate the regulatory role of CCDC137 in tumor growth. B Tumor volume growth curves were plotted over 28 days after tumor cell inoculation. C Tumor weights of T24-shCtrl and T24-shCCDC137-1 groups were measured on day 28. D The Graphical Abstract described the key results in this study. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance

Journal: Journal of Translational Medicine

Article Title: CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD

doi: 10.1186/s12967-025-07033-w

Figure Lengend Snippet: In vivo validation of CCDC137 regulating tumor growth. A Subcutaneous xenograft models were established in nude mice to validate the regulatory role of CCDC137 in tumor growth. B Tumor volume growth curves were plotted over 28 days after tumor cell inoculation. C Tumor weights of T24-shCtrl and T24-shCCDC137-1 groups were measured on day 28. D The Graphical Abstract described the key results in this study. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, no statistical significance

Article Snippet: The shCCDC137 lentiviral particles and corresponding control lentiviral particles (shCtrl) were purchased from Genechem Co., Ltd (Shanghai, China).

Techniques: In Vivo, Biomarker Discovery

NSDHL knockdown suppresses tumor initiation and growth in tumor spheroid-injected xenograft tumor models. (A) Representative flow cytometry histogram of mCherry-positive cells sorted from NSDHL shRNA (shNSDHL) or control shRNA (shCtrl)-tagged mCherry-transduced MCF-7 cells. (B) Representative confocal images of mCherry-positive cells in shNSDHL- or shCtrl-spheroids. mCherry (red) and DAPI (blue). Scale bar: 100 μm C-E. NSDHL mRNA and protein levels and representative western blot images of NSDHL and mCherry in shNSDHL-MCF-7 spheroids relative to shCtrl-MCF-7 spheroids by qRT-PCR ( n = 6) and western blot analysis ( n = 6). F-G. Representative flow cytometry dot plots and quantification of CD44+/CD24 − cells in shCtrl and shNSDHL MCF-7 spheroids ( n = 3). H-I. Representative flow cytometry dot plots and quantification of ALDH + cells in shCtrl- and shNSDHL-MCF-7 spheroids using ALDEFLUOR assay ( n = 3). J. Tumor volume was measured weekly in shCtrl- or shNSDHL-MCF-7 spheroid-injected mice ( n = 6) for 56 days post-injection. K-L. Gross images and wet weights of tumors removed from shNSDHL- or shCtrl-MCF-7 spheroid-injected mice ( n = 6) at 56 days post-injection. M-N. Representative western blot images and quantification data of NSDHL proteins in shNSDHL-MCF-7 tumors compared to shCtrl-MCF-7 tumors ( n = 6). O. Representative NSDHL and mCherry immunohistochemistry images and H&E images of shNSDHL- or shCtrl-MCF-7 tumor tissues. Scale bar: 100 μm. The bar graph shows the mean ± standard deviation. * P < 0.05, ** P < 0.01, *** P < 0.001 as compared to shCtrl using unpaired t-tests

Journal: BMC Cancer

Article Title: NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-β/Smad signaling pathway in MCF-7 tumor spheroid

doi: 10.1186/s12885-024-13143-3

Figure Lengend Snippet: NSDHL knockdown suppresses tumor initiation and growth in tumor spheroid-injected xenograft tumor models. (A) Representative flow cytometry histogram of mCherry-positive cells sorted from NSDHL shRNA (shNSDHL) or control shRNA (shCtrl)-tagged mCherry-transduced MCF-7 cells. (B) Representative confocal images of mCherry-positive cells in shNSDHL- or shCtrl-spheroids. mCherry (red) and DAPI (blue). Scale bar: 100 μm C-E. NSDHL mRNA and protein levels and representative western blot images of NSDHL and mCherry in shNSDHL-MCF-7 spheroids relative to shCtrl-MCF-7 spheroids by qRT-PCR ( n = 6) and western blot analysis ( n = 6). F-G. Representative flow cytometry dot plots and quantification of CD44+/CD24 − cells in shCtrl and shNSDHL MCF-7 spheroids ( n = 3). H-I. Representative flow cytometry dot plots and quantification of ALDH + cells in shCtrl- and shNSDHL-MCF-7 spheroids using ALDEFLUOR assay ( n = 3). J. Tumor volume was measured weekly in shCtrl- or shNSDHL-MCF-7 spheroid-injected mice ( n = 6) for 56 days post-injection. K-L. Gross images and wet weights of tumors removed from shNSDHL- or shCtrl-MCF-7 spheroid-injected mice ( n = 6) at 56 days post-injection. M-N. Representative western blot images and quantification data of NSDHL proteins in shNSDHL-MCF-7 tumors compared to shCtrl-MCF-7 tumors ( n = 6). O. Representative NSDHL and mCherry immunohistochemistry images and H&E images of shNSDHL- or shCtrl-MCF-7 tumor tissues. Scale bar: 100 μm. The bar graph shows the mean ± standard deviation. * P < 0.05, ** P < 0.01, *** P < 0.001 as compared to shCtrl using unpaired t-tests

Article Snippet: shRNA lentiviral particles (shNSDHL) (LPP-HSH103352-LVRU6MH-c-100) and control shRNA lentiviral particles (shCtrl) (LPP-CSHCTR001-LVRU6MH-025-C) were purchased from GeneCopoeia (Rockville, MD, USA).

Techniques: Knockdown, Injection, Flow Cytometry, shRNA, Control, Western Blot, Quantitative RT-PCR, Immunohistochemistry, Standard Deviation

Incidence of palpable tumors in mice injected with  shCtrl  or shNSDHL cells

Journal: BMC Cancer

Article Title: NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-β/Smad signaling pathway in MCF-7 tumor spheroid

doi: 10.1186/s12885-024-13143-3

Figure Lengend Snippet: Incidence of palpable tumors in mice injected with shCtrl or shNSDHL cells

Article Snippet: shRNA lentiviral particles (shNSDHL) (LPP-HSH103352-LVRU6MH-c-100) and control shRNA lentiviral particles (shCtrl) (LPP-CSHCTR001-LVRU6MH-025-C) were purchased from GeneCopoeia (Rockville, MD, USA).

Techniques: Injection

NSDHL knockdown reduced the BCSC population with CD44+/CD24 − phenotype and ALDH activity in tumor spheroid-injected xenograft tumor tissues, accompanied by decreased Smad2/3 phosphorylation and SOX2 expression. A-D. Representative flow cytometry histograms, dot plots, and quantification of CD44 + and CD24- cells in control (shCtrl) and NSDHL shRNA (shNSDHL)-transduced MCF-7 tumors ( n = 4). E-F. Representative flow cytometry dot plots and quantification of ALDH + cells in shCtrl- and shNSDHL MCF-7 tumors using ALDEFLUOR assay ( n = 4). G. Representative double immunohistochemistry images of CD44 + and ALDH1A1 + cells in shCtrl and shNSDHL MCF-7 tumors. CD44 (green), ALDH1A1(red). Double CD44+/ALDH1A1 + cells (arrow). H-O. Representative western blot images and quantification data of phopho-Smad2 and 3, Smad2, Smad3, SOX2, and NANOG levels in shNSDHL MCF-7 tumors relative to shCtrl MCF-7 tumors ( n = 5). All graphs show the mean ± standard deviation. * P < 0.05, compared with shCtrl using unpaired t-tests

Journal: BMC Cancer

Article Title: NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-β/Smad signaling pathway in MCF-7 tumor spheroid

doi: 10.1186/s12885-024-13143-3

Figure Lengend Snippet: NSDHL knockdown reduced the BCSC population with CD44+/CD24 − phenotype and ALDH activity in tumor spheroid-injected xenograft tumor tissues, accompanied by decreased Smad2/3 phosphorylation and SOX2 expression. A-D. Representative flow cytometry histograms, dot plots, and quantification of CD44 + and CD24- cells in control (shCtrl) and NSDHL shRNA (shNSDHL)-transduced MCF-7 tumors ( n = 4). E-F. Representative flow cytometry dot plots and quantification of ALDH + cells in shCtrl- and shNSDHL MCF-7 tumors using ALDEFLUOR assay ( n = 4). G. Representative double immunohistochemistry images of CD44 + and ALDH1A1 + cells in shCtrl and shNSDHL MCF-7 tumors. CD44 (green), ALDH1A1(red). Double CD44+/ALDH1A1 + cells (arrow). H-O. Representative western blot images and quantification data of phopho-Smad2 and 3, Smad2, Smad3, SOX2, and NANOG levels in shNSDHL MCF-7 tumors relative to shCtrl MCF-7 tumors ( n = 5). All graphs show the mean ± standard deviation. * P < 0.05, compared with shCtrl using unpaired t-tests

Article Snippet: shRNA lentiviral particles (shNSDHL) (LPP-HSH103352-LVRU6MH-c-100) and control shRNA lentiviral particles (shCtrl) (LPP-CSHCTR001-LVRU6MH-025-C) were purchased from GeneCopoeia (Rockville, MD, USA).

Techniques: Knockdown, Activity Assay, Injection, Expressing, Flow Cytometry, Control, shRNA, Immunohistochemistry, Western Blot, Standard Deviation

Depletion of RALA or RALB reduces MDA-MB-468 tumor growth and is associated with changes in the tumor microenvironment. ( A ) Western blots displaying RALA and RALB expression in the MDA-MB-468 shRNA control (shCTRL), shRALA, and shRALB cells. ImageJ was used for quantification. ( B , C ) Effects of stable knockdown of RALA or RALB in MDA-MB-468 cells on 2D growth as measured by MTT (( B ), n = 4), and 3D growth as measured by GILA (( C ), n = 4) *, p < 0.05. ( D ) Stable knockdown of RALA or RALB had no effect on MDA-MB-468 cell migration (left: representative images, right: composite mean values, n = 2). ( E ) Comparison of tumor growth following orthotopic mammary fat pad injection of MDA-MB-468 shCtrl ( n = 20), shRALA ( n = 20), or shRALB ( n = 20). Results were combined from three independent experiments. ( F – H ) MDA-MB-468 shCTRL ( n = 9), shRALA ( n = 10), and shRALB ( n = 10) tumors IHC stained for ( F ) Ki-67, ( G ) CC3, or ( H ) CD31. ROIs were determined on each image separating the tumor from stroma before color deconvolution to extract DAB staining. A signal threshold (equivalent for each image) was then applied to the samples before measurement of the ROIs was performed to measure the % area of target staining in each region. Three representative photos from each sample were separately analyzed, and the mean values were used for comparisons among groups. *, p < 0.05. ( I ) MDA-MB-468 tumors stained with Masson’s Trichrome, denoted by white arrows, to analyze the collagen deposition in shCTRL ( n = 7), shRALA ( n = 8), or shRALB ( n = 9) MDA-MB-468 tumors. *, p < 0.05. ( J , K ) Graphs summarize the relative amounts of secreted proteins detected in the conditioned media from the MDA-MB-468 shCTRL, shRALA, and shRALB cultures.

Journal: Cancers

Article Title: The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer

doi: 10.3390/cancers16173043

Figure Lengend Snippet: Depletion of RALA or RALB reduces MDA-MB-468 tumor growth and is associated with changes in the tumor microenvironment. ( A ) Western blots displaying RALA and RALB expression in the MDA-MB-468 shRNA control (shCTRL), shRALA, and shRALB cells. ImageJ was used for quantification. ( B , C ) Effects of stable knockdown of RALA or RALB in MDA-MB-468 cells on 2D growth as measured by MTT (( B ), n = 4), and 3D growth as measured by GILA (( C ), n = 4) *, p < 0.05. ( D ) Stable knockdown of RALA or RALB had no effect on MDA-MB-468 cell migration (left: representative images, right: composite mean values, n = 2). ( E ) Comparison of tumor growth following orthotopic mammary fat pad injection of MDA-MB-468 shCtrl ( n = 20), shRALA ( n = 20), or shRALB ( n = 20). Results were combined from three independent experiments. ( F – H ) MDA-MB-468 shCTRL ( n = 9), shRALA ( n = 10), and shRALB ( n = 10) tumors IHC stained for ( F ) Ki-67, ( G ) CC3, or ( H ) CD31. ROIs were determined on each image separating the tumor from stroma before color deconvolution to extract DAB staining. A signal threshold (equivalent for each image) was then applied to the samples before measurement of the ROIs was performed to measure the % area of target staining in each region. Three representative photos from each sample were separately analyzed, and the mean values were used for comparisons among groups. *, p < 0.05. ( I ) MDA-MB-468 tumors stained with Masson’s Trichrome, denoted by white arrows, to analyze the collagen deposition in shCTRL ( n = 7), shRALA ( n = 8), or shRALB ( n = 9) MDA-MB-468 tumors. *, p < 0.05. ( J , K ) Graphs summarize the relative amounts of secreted proteins detected in the conditioned media from the MDA-MB-468 shCTRL, shRALA, and shRALB cultures.

Article Snippet: MDA-MB-468 parental cells were transduced with the Origene lentiviruses shCTRL (TR30021V), shRALA (TL309957VC, 5′-CTGGTTGGTAACAAATCAGATTTAGAAGA-3′), and shRALB (TL309956VD, 5′-GAACAGATTCTCCGTGTGAAGGCTGAAGA-3′).

Techniques: Western Blot, Expressing, shRNA, Control, Knockdown, Migration, Comparison, Injection, Staining

Loss of RALA or RALB does not negatively impact SKBR3 tumor growth or viability. ( A ) Western blots displaying RALA and RALB expression in the SKBR3 shRNA control (shCTRL), shRALA, and shRALB cells. ImageJ was used for quantification. ( B ) Comparison of tumor growth following orthotopic mammary fat pad injection of SKBR3 shCTRL ( n = 10), shRALA ( n = 9), or shRALB ( n = 10). Results were from a single experiment. ( C – E ) Effects of stable knockdown of RALA or RALB in SKBR3 cells on 2D growth as measured by MTT (( C ), n = 5), 3D growth as measured by GILA (( D ), n = 5), and cell migration (( E ), n = 2). *, p < 0.05.

Journal: Cancers

Article Title: The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer

doi: 10.3390/cancers16173043

Figure Lengend Snippet: Loss of RALA or RALB does not negatively impact SKBR3 tumor growth or viability. ( A ) Western blots displaying RALA and RALB expression in the SKBR3 shRNA control (shCTRL), shRALA, and shRALB cells. ImageJ was used for quantification. ( B ) Comparison of tumor growth following orthotopic mammary fat pad injection of SKBR3 shCTRL ( n = 10), shRALA ( n = 9), or shRALB ( n = 10). Results were from a single experiment. ( C – E ) Effects of stable knockdown of RALA or RALB in SKBR3 cells on 2D growth as measured by MTT (( C ), n = 5), 3D growth as measured by GILA (( D ), n = 5), and cell migration (( E ), n = 2). *, p < 0.05.

Article Snippet: MDA-MB-468 parental cells were transduced with the Origene lentiviruses shCTRL (TR30021V), shRALA (TL309957VC, 5′-CTGGTTGGTAACAAATCAGATTTAGAAGA-3′), and shRALB (TL309956VD, 5′-GAACAGATTCTCCGTGTGAAGGCTGAAGA-3′).

Techniques: Western Blot, Expressing, shRNA, Control, Comparison, Injection, Knockdown, Migration

Fig. 2 NSDHL knockdown decreases viability, proliferation, and colony and sphere formation abilities of BT-20 and MDA-MB-231 cells. a, b Data of cell viability and cell cycle in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); c, d Representative images and data analyzed in colony formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); e Representative image and data analyzed in 3D sphere formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). All data represent the means ± standard deviations of three independent experiments, each performed in triplicates. *p < 0.05, **p < 0.01, ***p < 0.001

Journal: BMC cancer

Article Title: NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis.

doi: 10.1186/s12885-020-06840-2

Figure Lengend Snippet: Fig. 2 NSDHL knockdown decreases viability, proliferation, and colony and sphere formation abilities of BT-20 and MDA-MB-231 cells. a, b Data of cell viability and cell cycle in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); c, d Representative images and data analyzed in colony formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); e Representative image and data analyzed in 3D sphere formation of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). All data represent the means ± standard deviations of three independent experiments, each performed in triplicates. *p < 0.05, **p < 0.01, ***p < 0.001

Article Snippet: Short hairpin RNA (shRNA) lentiviral transduction Precisely, 4 × 105 MDA-MB-231 cells were seeded in each well of 12-well plate 24 h prior to viral infection and were replaced with media containing 5 μg/ml polybrene® (sc-134220, Santa Cruz) and 20 μl of NSDHLtargeting shRNA lentiviral particles (shNSDHL) (sc90849-V, Santa Cruz) or control shRNA lentiviral particles (shCtrl) (sc-108080, Santa Cruz).

Techniques: Knockdown, Transfection, Control

Fig. 3 NSDHL knockdown decreases the migration and invasion abilities of BT-20 and MDA-MB-231 cells. a,b,c Representative images and data analyzed in transwell migration assay, invasion assay and, wound healing assay of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). Data represent the means ± standard deviations of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001

Journal: BMC cancer

Article Title: NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis.

doi: 10.1186/s12885-020-06840-2

Figure Lengend Snippet: Fig. 3 NSDHL knockdown decreases the migration and invasion abilities of BT-20 and MDA-MB-231 cells. a,b,c Representative images and data analyzed in transwell migration assay, invasion assay and, wound healing assay of BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). Data represent the means ± standard deviations of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001

Article Snippet: Short hairpin RNA (shRNA) lentiviral transduction Precisely, 4 × 105 MDA-MB-231 cells were seeded in each well of 12-well plate 24 h prior to viral infection and were replaced with media containing 5 μg/ml polybrene® (sc-134220, Santa Cruz) and 20 μl of NSDHLtargeting shRNA lentiviral particles (shNSDHL) (sc90849-V, Santa Cruz) or control shRNA lentiviral particles (shCtrl) (sc-108080, Santa Cruz).

Techniques: Knockdown, Migration, Transwell Migration Assay, Invasion Assay, Wound Healing Assay, Transfection, Control

Fig. 4 NSDHL knockdown suppresses total cholesterol level and promotes erlotinib response in MDA-MB-231 cell. a Total cholesterol levels measured in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); b Dose-response curve of erlotinib in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); c Representative western blot images of NSDHL, EGFR, and precursor and mature SREBP-1 and data of relative expression levels of NSDHL, EGFR, and precursor SREBP-1 in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). Data represent the mean ± standard deviation of three independent experiments. *p < 0.05, ***p < 0.001

Journal: BMC cancer

Article Title: NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis.

doi: 10.1186/s12885-020-06840-2

Figure Lengend Snippet: Fig. 4 NSDHL knockdown suppresses total cholesterol level and promotes erlotinib response in MDA-MB-231 cell. a Total cholesterol levels measured in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); b Dose-response curve of erlotinib in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM); c Representative western blot images of NSDHL, EGFR, and precursor and mature SREBP-1 and data of relative expression levels of NSDHL, EGFR, and precursor SREBP-1 in BT-20 and MDA-MB-231 cells transfected with NSDHL siRNA or control siRNA (20 nM). Data represent the mean ± standard deviation of three independent experiments. *p < 0.05, ***p < 0.001

Article Snippet: Short hairpin RNA (shRNA) lentiviral transduction Precisely, 4 × 105 MDA-MB-231 cells were seeded in each well of 12-well plate 24 h prior to viral infection and were replaced with media containing 5 μg/ml polybrene® (sc-134220, Santa Cruz) and 20 μl of NSDHLtargeting shRNA lentiviral particles (shNSDHL) (sc90849-V, Santa Cruz) or control shRNA lentiviral particles (shCtrl) (sc-108080, Santa Cruz).

Techniques: Knockdown, Transfection, Control, Western Blot, Expressing, Standard Deviation

Fig. 5 NSDHL knockdown suppressed tumor growth and lung metastasis of MDA-MB-231 xenograft mice. a, b Data of relative NSDHL mRNA level analyzed by real-time RT-PCR and representative western blot images of NSDHL in MDA-MB-231 cells transduced with NSDHL shRNA or control shRNA lentivirus; c Data of tumor volume measured weekly in NSDHL shRNA or control shRNA mice; d Gross images and wet weight of tumors removed from NSDHL shRNA or control shRNA mice at 44 days post-injection; e Representative NSDHL immunohistochemistry image and scores analyzed from NSDHL shRNA or control shRNA tumor tissues; f Gross and H&E images of lungs and data of metastatic foci analyzed from NSDHL shRNA or control shRNA lung tissues. In vitro data represent the means ± standard deviations of three independent experiments. Animal data represent the means ± standard deviations of five mice per group. *p < 0.05, **p < 0.01

Journal: BMC cancer

Article Title: NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis.

doi: 10.1186/s12885-020-06840-2

Figure Lengend Snippet: Fig. 5 NSDHL knockdown suppressed tumor growth and lung metastasis of MDA-MB-231 xenograft mice. a, b Data of relative NSDHL mRNA level analyzed by real-time RT-PCR and representative western blot images of NSDHL in MDA-MB-231 cells transduced with NSDHL shRNA or control shRNA lentivirus; c Data of tumor volume measured weekly in NSDHL shRNA or control shRNA mice; d Gross images and wet weight of tumors removed from NSDHL shRNA or control shRNA mice at 44 days post-injection; e Representative NSDHL immunohistochemistry image and scores analyzed from NSDHL shRNA or control shRNA tumor tissues; f Gross and H&E images of lungs and data of metastatic foci analyzed from NSDHL shRNA or control shRNA lung tissues. In vitro data represent the means ± standard deviations of three independent experiments. Animal data represent the means ± standard deviations of five mice per group. *p < 0.05, **p < 0.01

Article Snippet: Short hairpin RNA (shRNA) lentiviral transduction Precisely, 4 × 105 MDA-MB-231 cells were seeded in each well of 12-well plate 24 h prior to viral infection and were replaced with media containing 5 μg/ml polybrene® (sc-134220, Santa Cruz) and 20 μl of NSDHLtargeting shRNA lentiviral particles (shNSDHL) (sc90849-V, Santa Cruz) or control shRNA lentiviral particles (shCtrl) (sc-108080, Santa Cruz).

Techniques: Knockdown, Quantitative RT-PCR, Western Blot, Transduction, shRNA, Control, Injection, Immunohistochemistry, In Vitro